Plain-English translation of NCT07692165 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called INT-210 in capsule form to see if it can help people with active ulcerative colitis—a condition causing inflammation and bleeding in the colon. Researchers want to learn whether the medication is safe and whether it actually reduces symptoms like diarrhea, bleeding, and inflammation. You would receive one of two different doses of this treatment.
Ulcerative colitis can be serious and hard to treat, especially when patients don't respond well to existing medications. This trial aims to offer a new option for people who have already tried several other treatments without success or who couldn't tolerate them.
You likely qualify if…
You likely don't qualify if…
You would visit the study clinic multiple times for check-ups, blood tests, and possibly a scope procedure to monitor your bowel inflammation. You would take the medication capsules as directed and keep track of your symptoms. The trial will compare how well two different dose levels of the treatment work and monitor you closely for any side effects throughout the study period.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
China